Emily V. '. W.
- Country
- The Netherlands
- Department
- Department of Pulmonology
Research Overview
- A Phase 1 Study of AIR-001 in Adults with Alpha-1 Antitrypsin Deficiency
- Phase 1/2 Open‑Label Multi‑Center Dose‑Escalation and Expansion Study of Intravenous TSRA‑196 in Adults with PiZZ‑Genotype Alpha‑1 Antitrypsin Deficiency‑Related Lung and/or Liver Disease
- Efficacy and Safety of Human Alpha1-Proteinase Inhibitor Inhalation in Adults with Congenital Alpha-1 Antitrypsin Deficiency and Moderate to Severe Airflow Limitation
Data & Insights
Has run more than one trial at 11 of 54 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating patients with congenital Alpha-1 Antitrypsin Deficiency, focusing particularly on cases involving moderate to severe airflow limitations.
- Airway Function Management
- Pulmonary Disease Treatment
- Respiratory Function Assessment
Their work encompasses the evaluation of innovative therapeutic approaches for managing chronic respiratory conditions.
Genetic Disorders
The investigator focuses on the treatment of inherited metabolic disorders, with particular emphasis on genetic conditions affecting respiratory function.
- Congenital Disease Management
- Genetic Deficiency Treatment
- Inherited Disorder Therapy
Their expertise extends to long-term therapeutic interventions for patients with genetic respiratory disorders.
Therapeutic Innovation
The investigator evaluates novel treatment approaches for chronic respiratory disorders, focusing on inhalation therapy applications.
- Advanced Respiratory Therapeutics
- Innovative Treatment Protocols
- Long-term Disease Management
Their work involves assessing therapeutic interventions for improving respiratory function in genetic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.